Clinical Trial Update: An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive Chronic Hepatitis B in Vietnam

View source ↗

Summary

Observational study of Pegasys (peginterferon alfa-2a) in HBeAg-positive chronic hepatitis B patients in Vietnam; study terminated with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis B, Chronic | Status: TERMINATED | Results posted: 2016-06-22